Ghana - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Ghana Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 23.4% year on year. In 2019, the country was ranked number 91 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 266 Cases. Ghana is overtaken by Namibia, which was ranked number 90 with 289 Cases and is followed by Egypt with 264 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 266.00 |
2018 | 231.00 |
2017 | 209.00 |
2016 | 107.00 |
2015 | 72.00 |
How does Ghana rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
89 |
#89
Guinea
|
303 | 2019 | -17.0 % | +23.6 % | View data | |
91 |
#91
Ghana
|
266 | 2019 | +15.2 % | +23.4 % | View data | |
92 |
#92
Egypt
|
264 | 2019 | +85.9 % | +25.1 % | View data |